Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by CNInvestingon Aug 18, 2016 6:49pm
91 Views
Post# 25156521

RE:I count 12 variations of ibuprofen....

RE:I count 12 variations of ibuprofen....A real joke honestly. They don't deny it, it's written in their own annual form what the 60 launches are. It's nothing more than this :

Concordia International grows and diversifies its product portfolio through acquisitions and organic growth, pursuant to
which Concordia International has developed a pipeline of products, which consists of approximately 60 anticipated
product launches over the next three years, mostly in the form of in-licensed developments for molecules. This pipeline
consists of: (i) reformulations or new dosages of existing products, which are developed in-house, (ii) the launch of existing
products in new countries, and (iii) in-licensed products that reach across Concordia International’s various markets.

select1011 wrote: ... in the AMCo version of 200 box-lunch drugs Did MT pay $3B+ for a Kraft Dinner recipe book? Did you buy while insiders are apparently selling?


<< Previous
Bullboard Posts
Next >>